Cancer - Solid Tumors and B-Cell Non-Hodgkin's Lymphoma

1 clinical trials · Condition

Record	Firm	Date
Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma (NCT01471210)	Bristol-Myers Squibb	2012-02-01

Every clearance here is in the API, with alerts when new ones post.